The landscape of American healthcare has evolved into a complex and intricate system, vastly different from its simpler origins of house calls and direct payments. The advent of advanced medical technologies, expensive procedures, and profit-driven insurance has transformed healthcare into a sprawling industry that can overwhelm individuals and businesses alike.
Middlemen in healthcare emerged to help manage the growing complexities of the system, offering solutions to providers, patients, and employers in tasks like billing, insurance plan selection, and drug price negotiation. However, these middlemen have now become obstacles to progress, perpetuating inefficiencies that only exacerbate the issues within medicine.
Unlike disruptive intermediaries in other industries that focus on lowering prices, broadening access, and increasing convenience for customers, healthcare middlemen often prioritize the profits of drug companies and insurers over the well-being of patients and employers. This skewed focus has led to soaring healthcare costs, making navigating the healthcare system even more challenging for individuals.
Two of the most influential types of healthcare middlemen are Pharmacy Benefit Managers (PBMs) and brokers/ Administrative Services Only (ASOs). PBMs were initially created to assist insurers in managing the vast number of medications on the market and negotiating lower prices. However, they now work in tandem with pharmaceutical companies to secure better formulary placement for high-cost brand-name medications, driving up overall healthcare costs and premiums.
On the other hand, brokers and ASOs operate within traditional insurance models, failing to address the current challenges in healthcare. Brokers still recommend expensive plans from large insurers, while ASOs are incentivized to increase healthcare costs as it directly impacts their earnings.
To combat these issues, elected officials must push for legislation that requires transparency around PBM rebates and ensures that savings are passed on to patients and payers. Businesses should demand brokers to present more value-based insurance options, and self-insured companies should consider partnering with accountable care organizations (ACOs) through third-party administrators (TPAs) to focus on preventive care and improving health outcomes.
By recognizing and addressing the financial incentives of middlemen in healthcare, we can begin to unravel the complexities within the system and work towards a more efficient and affordable healthcare landscape for all Americans.
